Espinel-Ingroff A, Pfaller M, Erwin M E, Jones R N
Medical College of Virginia/Virginia Commonwealth University, Richmond 23298-0049, USA.
J Clin Microbiol. 1996 Apr;34(4):848-52. doi: 10.1128/jcm.34.4.848-852.1996.
An interlaboratory evaluation (two centers) of the Etest method was conducted for testing the antifungal susceptibilities of yeasts. The MICs of amphotericin B, fluconazole, flucytosine, itraconazole, and ketoconazole were determined for 83 isolates of Candida spp., Cryptococcus neoformans, and Torulopsis glabrata. Two buffered (phosphate buffer) culture media were evaluated: solidified RPMI 1640 medium with 2% glucose and Casitone agar. MIC endpoints were determined after both 24 and 48 h of incubation at 35 degrees C. Analysis of 3,420 MICs demonstrated higher interlaboratory agreement (percentage of MIC pairs within a 2-dilution range) with Casitone medium than with RPMI 1640 medium when testing amphotericin B (84 to 90% versus 1 to 4%), itraconazole (87% versus 63 to 74%), and ketoconazole (94 to 96% versus 88 to 90%). In contrast, better interlaboratory reproducibility was determined between fluconazole MIC pairs when RPMI 1640 medium rather than Casitone medium was used (96 to 98% versus 77 to 90%). Comparison of the flucytosine MICs obtained with RPMI 1640 medium revealed greater than 80% reproducibility. The study suggests the potential value of the Etest as a convenient alternative method for testing the susceptibilities of yeasts. It also indicates the need for further optimization of medium formulations and MIC endpoint criteria to improve interlaboratory agreement.
开展了一项实验室间评估(两个中心),采用Etest方法检测酵母的抗真菌药敏性。对83株念珠菌属、新型隐球菌和光滑假丝酵母分离株测定了两性霉素B、氟康唑、氟胞嘧啶、伊曲康唑和酮康唑的最低抑菌浓度(MIC)。评估了两种缓冲(磷酸盐缓冲液)培养基:含2%葡萄糖的凝固RPMI 1640培养基和酪蛋白胨琼脂。在35℃孵育24小时和48小时后确定MIC终点。对3420个MIC进行分析表明,在检测两性霉素B(84%至90%对1%至4%)、伊曲康唑(87%对63%至74%)和酮康唑(94%至96%对88%至90%)时,与RPMI 1640培养基相比,酪蛋白胨培养基的实验室间一致性更高(MIC值在2倍稀释范围内的配对百分比)。相比之下,使用RPMI 1640培养基而非酪蛋白胨培养基时,氟康唑MIC配对之间的实验室间重复性更好(96%至98%对77%至90%)。对用RPMI 1640培养基获得的氟胞嘧啶MIC进行比较,发现重复性大于80%。该研究表明Etest作为检测酵母药敏性的一种便捷替代方法具有潜在价值。它还表明需要进一步优化培养基配方和MIC终点标准,以提高实验室间的一致性。